Status:

COMPLETED

Comparative Study of Safety and Efficacy of Heavyweight and Partially Absorbable Mesh in Inguinal Hernia Repair

Lead Sponsor:

Samyang Biopharmaceuticals Corporation

Conditions:

Hernia, Inguinal

Eligibility:

MALE

20-85 years

Phase:

PHASE4

Brief Summary

Proflex® Mesh (partially absorbable mesh, Korea) and Marlex® Mesh (heavyweight mesh) will be used for inguinal hernia repair to compare the safety and efficacy (pain score, quality of life)of two devi...

Eligibility Criteria

Inclusion

  • Male patients \>=20 years =\<85 years old
  • Patients with Unilateral hernia
  • Patients without previous operations in lower part of abdomen
  • Patients capable to understand the explanation about purpose and method of the trial, and write an Informed Concent Form
  • Patients capable to participate during the period of the trial

Exclusion

  • Previous hernia repair at the same site
  • Incarcerated hernia
  • Strangulated hernia
  • Patients to whom and open surgery cannot be indicated
  • Previous urological surgery
  • Immune incompetence of patient: AIDS, vesical fibrosis, etc.
  • Patients with AIHD or patients who take immunosuppressive drugs
  • Patients with liver disease (ASL, AST ≥ normal value by more than 3 times)
  • Patients with kidney disease (creatinine\>2.0mg/dL)
  • Patients on anti-coagulants
  • Patients with severe systematic disease
  • Patients with malignant tumor
  • Patients with infection or with the predicted problem of surgery site healing
  • Participation in another clinical study within the last 30 days
  • Patients whose participation is considered inappropriate according to other except above mentioned clinical condition

Key Trial Info

Start Date :

April 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2014

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT01877122

Start Date

April 1 2013

End Date

December 1 2014

Last Update

June 25 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Samyang Biopharmaceuticals

Seoul, South Korea